Iron deficiency in chronic thromboembolic pulmonary hypertension referred for balloon pulmonary angioplasty
ID is common in CTEPH patients eligible for BPA, most often without anaemia, and its prevalence depends critically on the definition used. Defining ID solely as TSAT <20 % may allow to identify a subgroup of patients with reduced exercise capacity.
Authors
- Laurent Bertoletti (ORCID: https://orcid.org/0000-0001-8214-3010)
- Muriel Salvat
- Bruno Degano (ORCID: https://orcid.org/0000-0003-1644-7264)
- Hélène Bouvaist (ORCID: https://orcid.org/0000-0002-8243-3971)
- Nicolas Piliero (ORCID: https://orcid.org/0000-0003-3020-6758)
Institutions
- Inserm (FR)
- Centre Hospitalier Universitaire de Grenoble (FR)
- Centre Hospitalier Universitaire de Saint-Étienne (FR)
- Université Jean Monnet (FR)
- Université Grenoble Alpes (FR)
Publication Details
- Journal
- Respiratory Medicine
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1016/j.rmed.2025.108219
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00